[
  {
    "ts": null,
    "headline": "Piper Sandler Lifts PT on Amgen (AMGN) to $342 From $328, Keeps an Overweight Rating",
    "summary": "Amgen Inc. (NASDAQ:AMGN) is one of the top most undervalued low volatility stocks to buy now. On August 25, Piper Sandler raised the firm’s price target on Amgen Inc. (NASDAQ:AMGN) to $342 from $328 while keeping an Overweight rating on the shares. The rating update came after the company’s quarterly results, with the firm stating that […]",
    "url": "https://finnhub.io/api/news?id=8667946c08ea5d63092467f6fc1830d27b2f829c73b8b935ee8d53c735bd2bd5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756617045,
      "headline": "Piper Sandler Lifts PT on Amgen (AMGN) to $342 From $328, Keeps an Overweight Rating",
      "id": 136596283,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen Inc. (NASDAQ:AMGN) is one of the top most undervalued low volatility stocks to buy now. On August 25, Piper Sandler raised the firm’s price target on Amgen Inc. (NASDAQ:AMGN) to $342 from $328 while keeping an Overweight rating on the shares. The rating update came after the company’s quarterly results, with the firm stating that […]",
      "url": "https://finnhub.io/api/news?id=8667946c08ea5d63092467f6fc1830d27b2f829c73b8b935ee8d53c735bd2bd5"
    }
  }
]